A
3.04
0.05 (1.74%)
| Previous Close | 2.99 |
| Open | 3.01 |
| Volume | 21,861 |
| Avg. Volume (3M) | 16,106 |
| Market Cap | 14,772,072 |
| Price / Sales | 1.51 |
| Price / Book | 0.520 |
| 52 Weeks Range | |
| Earnings Date | 1 Aug 2023 - 7 Aug 2023 |
| Operating Margin (TTM) | -152,750.00% |
| Diluted EPS (TTM) | -2.30 |
| Quarterly Revenue Growth (YOY) | -99.80% |
| Total Debt/Equity (MRQ) | 1.80% |
| Current Ratio (MRQ) | 5.94 |
| Return on Assets (TTM) | -29.96% |
| Return on Equity (TTM) | -81.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Aeterna Zentaris Inc. | Mixed | Mixed |
AIStockmoo Score
-1.0
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -5.0 |
| Technical Oscillators | 0.0 |
| Average | -1.00 |
|
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 1.32% |
| % Held by Institutions | 5.21% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |